BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 2569995)

  • 1. A comparison of acrivastine versus terfenadine and placebo in the treatment of chronic idiopathic urticaria.
    van Joost T; Blog FB; Westerhof W; Jansen FC; Starink TM; den Boer MS; Kuneman JJ; Harvey SG; Gibson JR
    J Int Med Res; 1989; 17 Suppl 2():14B-17B. PubMed ID: 2569995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of acrivastine versus hydroxyzine and placebo in the treatment of chronic idiopathic urticaria.
    Salo OP; Harvey SG; Calthrop JG; Gibson JR
    J Int Med Res; 1989; 17 Suppl 2():18B-21B. PubMed ID: 2569996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acrivastine versus terfenadine in the treatment of symptomatic dermographism--a double-blind, placebo-controlled study.
    Boyle J; Marks P; Gibson JR
    J Int Med Res; 1989; 17 Suppl 2():9B-13B. PubMed ID: 2570004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of acrivastine versus clemastine and placebo in the treatment of patients with chronic idiopathic urticaria.
    Leyh F; Harvey SG; Gibson JR; Manna VK
    J Int Med Res; 1989; 17 Suppl 2():22B-24B. PubMed ID: 2569997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of acrivastine versus chlorpheniramine in the treatment of chronic idiopathic urticaria.
    Gale AE; Harvey SG; Calthrop JG; Gibson JR
    J Int Med Res; 1989; 17 Suppl 2():25B-27B. PubMed ID: 2569998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. French multicentre double-blind study to evaluate the efficacy and safety of acrivastine as compared with terfenadine in seasonal allergic rhinitis.
    Gervais P; Bruttman G; Pedrali P; Charpin J; Michel FB; Grilliat JP
    J Int Med Res; 1989; 17 Suppl 2():47B-53B. PubMed ID: 2570002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acrivastine versus hydroxyzine in the treatment of cholinergic urticaria. A placebo-controlled study.
    Kobza Black A; Aboobaker J; Gibson JR; Harvey SG; Marks P
    Acta Derm Venereol; 1988; 68(6):541-4. PubMed ID: 2467496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acrivastine--an evaluation of initial and peak activity in human skin.
    Marks P; Manna VK; Gibson JR
    J Int Med Res; 1989; 17 Suppl 2():3B-8B. PubMed ID: 2569999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double-blind, placebo-controlled study of terfenadine and hydroxyzine in patients with chronic idiopathic urticaria.
    Boggs PB; Ellis CN; Grossman J; Washburne WF; Gupta AK; Ball R; Shulan D
    Ann Allergy; 1989 Dec; 63(6 Pt 2):616-20. PubMed ID: 2574555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind placebo controlled study of terfenadine in the treatment of chronic idiopathic urticaria.
    Salisbury J; Bor S; Blair C
    Br J Clin Pract; 1987 Aug; 41(8):859-61. PubMed ID: 2896512
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comparison of astemizole and terfenadine in the treatment of chronic urticaria. A randomized double-blind study of 40 patients].
    Paul E; Bödeker RH
    Z Hautkr; 1985; 60 Suppl 1():50-5. PubMed ID: 2859714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the new antihistamine acrivastine (BW 825C) versus cyproheptadine in the treatment of idiopathic cold urticaria.
    Neittaanmäki H; Fräki JE; Gibson JR
    Dermatologica; 1988; 177(2):98-103. PubMed ID: 2901993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the onset of H1-antagonism with acrivastine and terfenadine by histamine bronchial challenge in volunteers.
    Rolan PE; Adams J; Posner J
    J Int Med Res; 1989; 17 Suppl 2():35B-39B. PubMed ID: 2570000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative study of astemizole and terfenadine in the treatment of chronic idiopathic urticaria. A randomized double-blind study of 40 patients.
    Paul E; Bödeker RH
    Ann Allergy; 1989 Apr; 62(4):318-20. PubMed ID: 2565098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged treatment with acrivastine for seasonal allergic rhinitis.
    Bruno G; D'Amato G; Del Giacco GS; Locci F; Gale NM; Errigo E; Melillo G
    J Int Med Res; 1989; 17 Suppl 2():40B-46B. PubMed ID: 2570001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative effects of loratadine and terfenadine in the treatment of chronic idiopathic urticaria.
    Belaich S; Bruttmann G; DeGreef H; Lachapelle JM; Paul E; Pedrali P; Tennstedt D
    Ann Allergy; 1990 Feb; 64(2 Pt 2):191-4. PubMed ID: 1967919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Terfenadine once daily in chronic urticaria. A multi-centre double-blind comparison of terfenadine once daily versus twice daily.
    Allergy; 1989 Sep; 44(7):447-52. PubMed ID: 2573286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acrivastine in allergic rhinitis: a review of clinical experience.
    Bojkowski CJ; Gibbs TG; Hellstern KH; Major EW; Mullinger B
    J Int Med Res; 1989; 17 Suppl 2():54B-68B. PubMed ID: 2570003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of efficacy and tolerability of terfenadine administered once daily versus twice daily in patients with chronic idiopathic urticaria.
    Paul E; Reinel D; Ulrich R; Köhler ME
    Ann Allergy; 1989 Oct; 63(4):340-2. PubMed ID: 2572189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acrivastine. A review of its pharmacological properties and therapeutic efficacy in allergic rhinitis, urticaria and related disorders.
    Brogden RN; McTavish D
    Drugs; 1991 Jun; 41(6):927-40. PubMed ID: 1715267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.